1. Home
  2. CODA vs IMA Comparison

CODA vs IMA Comparison

Compare CODA & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODA
  • IMA
  • Stock Information
  • Founded
  • CODA 1994
  • IMA 2019
  • Country
  • CODA United States
  • IMA United States
  • Employees
  • CODA N/A
  • IMA N/A
  • Industry
  • CODA Industrial Machinery/Components
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CODA Industrials
  • IMA Health Care
  • Exchange
  • CODA Nasdaq
  • IMA Nasdaq
  • Market Cap
  • CODA 88.8M
  • IMA 92.2M
  • IPO Year
  • CODA N/A
  • IMA N/A
  • Fundamental
  • Price
  • CODA $8.96
  • IMA $8.39
  • Analyst Decision
  • CODA Strong Buy
  • IMA
  • Analyst Count
  • CODA 1
  • IMA 0
  • Target Price
  • CODA $11.00
  • IMA N/A
  • AVG Volume (30 Days)
  • CODA 88.9K
  • IMA 78.6K
  • Earning Date
  • CODA 09-15-2025
  • IMA 11-15-2025
  • Dividend Yield
  • CODA N/A
  • IMA N/A
  • EPS Growth
  • CODA 15.09
  • IMA N/A
  • EPS
  • CODA 0.30
  • IMA N/A
  • Revenue
  • CODA $24,347,217.00
  • IMA $4,300,000.00
  • Revenue This Year
  • CODA $30.82
  • IMA N/A
  • Revenue Next Year
  • CODA $20.84
  • IMA N/A
  • P/E Ratio
  • CODA $28.40
  • IMA N/A
  • Revenue Growth
  • CODA 29.34
  • IMA N/A
  • 52 Week Low
  • CODA $5.76
  • IMA $7.57
  • 52 Week High
  • CODA $9.89
  • IMA $23.28
  • Technical
  • Relative Strength Index (RSI)
  • CODA 63.70
  • IMA N/A
  • Support Level
  • CODA $7.85
  • IMA N/A
  • Resistance Level
  • CODA $8.88
  • IMA N/A
  • Average True Range (ATR)
  • CODA 0.40
  • IMA 0.00
  • MACD
  • CODA 0.05
  • IMA 0.00
  • Stochastic Oscillator
  • CODA 97.44
  • IMA 0.00

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

Share on Social Networks: